2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Male Breast Cancer
Male breast cancer is a lesser-known but significant aspect of cancer research. Although it's comparatively rare, comprising less than 1% of all breast cancer cases, understanding its unique characteristics is crucial for effective diagnosis and treatment. Unlike in females, male breast cancer is often diagnosed at later stages due to less awareness and a lack of routine screening. Research in this field focuses on elucidating the genetic, hormonal, and environmental factors contributing to its development, as well as refining treatment strategies tailored specifically for male patients. Early detection methods and targeted therapies are areas of active investigation to improve outcomes for men affected by this condition. By advancing our understanding of male breast cancer, researchers aim to mitigate its impact and ensure equitable access to care for all individuals.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China